Human papillomavirus vaccination for adult women - Number 6 - June 2022 - Revista Brasileira de Ginecologia e Obstetrícia

Home » Issues » 2022, Volume 44, Number 6

Febrasgo Position Statement

Human papillomavirus vaccination for adult women – Number 6 – June 2022

Rev Bras Ginecol Obstet. 2022;44(6):631-635

DOI: 10.1055/s-0042-1751331

Views 2

Background

Human papillomavirus (HPV) infection is very prevalent. It occurs early, most of the times after onset of sexual activity. Among diseases associated with HPV infection, cervical cancer stands out. It continues to affect many women worldwide, especially in developing countries like Brazil, even though screening programs are effective when organized. The knowledge about genetic structure of different HPV types and the technological evolution provided vaccines development to prevent infection by oncogenic and non oncogenic HPV types.

Since 2007, HPV vaccines have been administered to adolescents in Immunization Programs around the world. They promote prevention of HPV cervical cancer and clinical lesions. In this target group, mainly between 9 and 12 years old, there is no concerns about vaccine safety and effectiveness. (,)

[…]

Read Full Text

opener
PDF - English Complete text JATS XML
How to Cite
Mendeley

Search

Search in:

Article type
abstract
book-review
brief-report
case-report -
correction
editorial
editorial -
letter
letter -
other -
rapid-communication
research-article
research-article -
review-article
review-article -
Section
Abstracts of Awarded Papers at the 50th Brazilian Congress of Gynecology and Obstetrics
Artigo de Revisão
Original Articles
Carta ao Editor
Case Report
Case Report and Treatment
Clinical Consensus Recommendation
Editorial
Editorial
Equipments and Methods
Erratum
Febrasgo Position Statement
Letter to the Editor
Methods and Techniques
Nota do Editor
Original Article
Original Article/Contraception
Original Article/Infertility
Original Article/Obstetrics
Original Article/Oncology
Original Article/Sexual Violence/Pediatric and Adolescent Gynecology
Original Article/Teaching and Training
Original Articles
Original Articles
Previous Note
Relato de Caso
Relatos de Casos
Resposta dos Autores
Resumo De Tese
Resumos de Teses
Review Article
Short Communication
Special Article
Systematic Review
Técnicas e Equipamentos
Thesis Abstract
Trabalhos Originais
Year / Volume
2024; v.46
2023; v.45
2022; v.44
2021; v.43
2020; v.42
2019; v.41
2018; v.40
2017; v.39
2016; v.38
2015; v.37
2014; v.36
2013; v.35
2012; v.34
2011; v.33
2010; v.32
2009; v.31
2008; v.30
2007; v.29
2006; v.28
2005; v.27
2004; v.26
2003; v.25
2002; v.24
2001; v.23
2000; v.22
1999; v.21
1998; v.20
ISSUE

Comments

Your email address will not be published. Required fields are marked *

Read Full Text

opener
PDF - English Complete text JATS XML
How to Cite
Mendeley

Search

Search in:

Article type
abstract
book-review
brief-report
case-report -
correction
editorial
editorial -
letter
letter -
other -
rapid-communication
research-article
research-article -
review-article
review-article -
Section
Abstracts of Awarded Papers at the 50th Brazilian Congress of Gynecology and Obstetrics
Artigo de Revisão
Original Articles
Carta ao Editor
Case Report
Case Report and Treatment
Clinical Consensus Recommendation
Editorial
Editorial
Equipments and Methods
Erratum
Febrasgo Position Statement
Letter to the Editor
Methods and Techniques
Nota do Editor
Original Article
Original Article/Contraception
Original Article/Infertility
Original Article/Obstetrics
Original Article/Oncology
Original Article/Sexual Violence/Pediatric and Adolescent Gynecology
Original Article/Teaching and Training
Original Articles
Original Articles
Previous Note
Relato de Caso
Relatos de Casos
Resposta dos Autores
Resumo De Tese
Resumos de Teses
Review Article
Short Communication
Special Article
Systematic Review
Técnicas e Equipamentos
Thesis Abstract
Trabalhos Originais
Year / Volume
2024; v.46
2023; v.45
2022; v.44
2021; v.43
2020; v.42
2019; v.41
2018; v.40
2017; v.39
2016; v.38
2015; v.37
2014; v.36
2013; v.35
2012; v.34
2011; v.33
2010; v.32
2009; v.31
2008; v.30
2007; v.29
2006; v.28
2005; v.27
2004; v.26
2003; v.25
2002; v.24
2001; v.23
2000; v.22
1999; v.21
1998; v.20
ISSUE

Leia também

close-button

How to cite this article

EndNote RIS

Electronic Document Format (Vancouver)

Roteli-Martins CM, Magno V, Santos ALF, Teixeira JC, Neves NA, Fialho SCAV. Human papillomavirus vaccination for adult women – Number 6 – June 2022. Rev Bras Ginecol Obstet 2022;44(6):631-5.

Electronic Document Format (ABNT)

Roteli-Martins, Cecília Maria; Magno, Valentino; Santos, André Luis Ferreira; Teixeira, Júlio César; Neves, Nilma Antas; Fialho, Susana Cristina Aidé Viviani. Human papillomavirus vaccination for adult women – Number 6 – June 2022. Rev Bras Ginecol Obstet, v. 44, n. 6, p. 631-635, Aug. 2022.

Electronic Document Format (APA)

Roteli-Martins, C. M., Magno, V., Santos, A. L. F., Teixeira, J. C., Neves, N. A., & Fialho, S. C. A. V. (2022). Human papillomavirus vaccination for adult women – Number 6 – June 2022. Rev Bras Ginecol Obstet, 44(6), 631-635.

Electronic Document Format (ISO)

Roteli-Martins, Cecília Maria and Magno, Valentino and Santos, André Luis Ferreira and Teixeira, Júlio César and Neves, Nilma Antas and Fialho, Susana Cristina Aidé Viviani. Human papillomavirus vaccination for adult women – Number 6 – June 2022. Rev Bras Ginecol Obstet [online]. 2022, vol. 44, n. 6, [cited 2024-06-26], pp.631-635. Available from: <https://journalrbgo.org/article/human-papillomavirus-vaccination-for-adult-women/>.
✕

Human papillomavirus vaccination for adult women – Number 6 – June 2022 |

Background

Human papillomavirus (HPV) infection is very prevalent. It occurs early, most of the times after onset of sexual activity. Among diseases associated with HPV infection, cervical cancer stands out. It continues to affect many women worldwide, especially in developing countries like Brazil, even though screening programs are effective when organized. The knowledge about genetic structure of different HPV types and the technological evolution provided vaccines development to prevent infection by oncogenic and non oncogenic HPV types. Since 2007, HPV vaccines have been administered to adolescents in Immunization Programs around the world. They promote prevention of HPV cervical cancer and clinical lesions. In this target group, mainly between 9 and 12 years old, there is no concerns about vaccine safety and effectiveness. (,) [...]